Streamlining PDC Production: Strategies from Peptide & Oligo Experts

Peptide Drug Conjugates (PDCs) continue to demonstrate significant advancements in targeted delivery and therapeutic effectiveness. Despite these strides, manufacturing challenges persist—particularly in scaling production, optimizing yields, managing costs, and maintaining quality through robust analytical methods. Our trusted partner offers a comprehensive, one-stop solution for peptide and oligonucleotide synthesis, as well as conjugation (e.g., PPMO), enabling seamless and efficient project execution. Their expertise in continuous purification and impurity analysis plays a vital role in enhancing both yield and quality control throughout the process.

In our latest white paper, we share practical solutions to purification and analytical challenges in PDC manufacturing, along with insights into synthesizing complex peptides, oligonucleotides, and conjugates. We support efficient PDC development through timely, precise technical communication and tailored proposals grounded in deep industry expertise. These capabilities streamline workflows, reduce in-process testing, and shorten lead times. Discover how our CDMO services can accelerate your peptide, oligo, and conjugate development.